Potential advancements in the treatment of difficult-to-treat glioblastoma through nanoparticle drug delivery.

Glioblastoma multiforme is the most common and the most aggressive primary brain tumor, with a median survival of 14 months. This dismal prognostic has turned research towards nanomedicine as a new...